Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

USA: A recent randomized controlled trial published in Obstetrics & Gynecology has found that platelet-rich plasma (PRP) ...

Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial ...

At week 16, 40 of 63 participants receiving ORKA-001 achieved PASI 100, corresponding to complete skin clearance.

Multiple randomized controlled trials have shown that tesamorelin, a growth hormone–releasing hormone analog, can selectively reduce visceral fat by about 15% over 26 weeks in HIV patients, with no ...

Johnson & Johnson has initiated the PERSIGMA randomized controlled trial (RCT), one of the first randomized studies ...

Data sources Five databases were searched from inception to March 2024. Study appraisal and synthesis Meta-analyses of randomised controlled trials (RCTs) comparing HIIT with MICT/CON were performed ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...